Literature DB >> 18274856

Natural course of desmoid-type fibromatosis.

Tomitaka Nakayama1, Tadao Tsuboyama, Junya Toguchida, Taisuke Hosaka, Takashi Nakamura.   

Abstract

BACKGROUND: Desmoid-type fibromatosis is a locally aggressive tumor known to have high potential for local recurrence after resection, while it exhibits self-limiting behavior and shows growth arrest or spontaneous regression in many patients. Thus, its natural course is not well known, and the proper treatment has not yet been established.
METHODS: We retrospectively reviewed clinical outcome and changes in tumor size in 11 consecutive patients with extremity and trunk desmoid-type fibromatoses, who were basically observed without any treatment after diagnosis.
RESULTS: For two patients in whom the tumors were initially incorrectly diagnosed as other tumors, surgical resection was performed. For another two patients, surgical resections were performed in the follow-up periods due to tumor enlargement or joint contracture. In all four patients who underwent surgery, tumors recurred shortly after resection and re-resection was not performed. During the follow-up periods with a median length of 56 months, ten tumors eventually stopped growing, and three of them regressed spontaneously. At the time of final follow-up, ten patients were alive with residual disease without severe morbidity. In one patient, the tumor enlarged to over 30 cm in diameter with a substantial functional deficit.
CONCLUSIONS: Simple observation is a noninvasive and function-preserving treatment for desmoid-type fibromatosis.

Entities:  

Mesh:

Year:  2008        PMID: 18274856     DOI: 10.1007/s00776-007-1187-1

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  11 in total

Review 1.  Immunotherapy in Sarcoma: Future Horizons.

Authors:  Melissa Burgess; Vikram Gorantla; Kurt Weiss; Hussein Tawbi
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

Review 2.  Desmoid tumors: clinical features and treatment options for advanced disease.

Authors:  Bernd Kasper; Philipp Ströbel; Peter Hohenberger
Journal:  Oncologist       Date:  2011-04-08

3.  Primary intracranial aggressive fibromatosis arising in sella turcica: illustrative case.

Authors:  Kenta Ujifuku; Eisakua Sadakata; Shiro Baba; Koichi Yoshida; Kensaku Kamada; Minoru Morikawa; Kuniko Abe; Kazuhiko Suyama; Yoichi Nakazato; Isao Shimokawa; Takayuki Matsuo
Journal:  J Neurosurg Case Lessons       Date:  2021-09-20

4.  Desmoid-Type Fibromatosis-Clinical Study of an Uncommon Disease.

Authors:  Sreekanth S Kumar; K Rajeevan; E Devarajan
Journal:  Indian J Surg Oncol       Date:  2019-11-04

5.  Extra-Abdominal Desmoid Tumor in the Donor Site of an Extended Latissimus Dorsi Flap.

Authors:  Jai-Kyong Pyon; Bo Young Kang; Goo-Hyun Mun; Sa-Ik Bang; Kap Sung Oh; So-Young Lim
Journal:  Arch Plast Surg       Date:  2016-01-15

6.  Characteristics of cultured desmoid cells with different CTNNB1 mutation status.

Authors:  Shunsuke Hamada; Hiroshi Urakawa; Eiji Kozawa; Eisuke Arai; Kunihiro Ikuta; Tomohisa Sakai; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Cancer Med       Date:  2015-12-21       Impact factor: 4.452

7.  Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Yoji Shido; Hiroshi Urakawa; Eisuke Arai; Naoki Ishiguro
Journal:  Cancers (Basel)       Date:  2012-02-07       Impact factor: 6.639

8.  Desmoid type fibromatosis: A case report with an unusual etiology.

Authors:  Syed Faisal Jafri; Obada Obaisi; Gerardo G Vergara; Joe Cates; Jaswinder Singh; Jennifer Feeback; Harathi Yandrapu
Journal:  World J Gastrointest Oncol       Date:  2017-09-15

9.  A Case of Spontaneous Regression of Recurrent Desmoid Tumor Originating From the Internal Obturator Muscle After Delivery.

Authors:  Takuya Sueishi; Takeshi Arizono; Kenjiro Nishida; Takahiro Hamada; Akihiko Inokuchi
Journal:  World J Oncol       Date:  2016-09-03

10.  Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.

Authors:  Tomohisa Sakai; Yoshihiro Nishida; Shunsuke Hamada; Hiroshi Koike; Kunihiro Ikuta; Takehiro Ota; Naoki Ishiguro
Journal:  Diagn Pathol       Date:  2017-08-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.